India to Saudi Arabia: Gatifloxacin Export Trade Route

The India to Saudi Arabia Gatifloxacin corridor is one of India's established pharmaceutical export routes, with 2 shipments documented worth a combined $26.9K USD. The route is dominated by DOSHI MEDICARE PRIVATE LIMITED, which alone accounts for roughly 100% of all export value, reflecting the consolidated nature of India's gatifloxacin manufacturing sector.

Across 1 active suppliers, the average shipment value stands at $13.5K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 78% of all shipments, consistent with gatifloxacin's non-urgent bulk-order profile.

Shipment activity peaks during October–December, with an average transit time of 28 days port-to-port. The route has recorded an annual growth rate of 27.7%, placing it at rank #14 among India's top gatifloxacin export destinations globally.

On the import side, key buyers of Indian gatifloxacin in Saudi Arabia include TO THE ORDER OF. TO THE ORDER OF is the single largest importer with 2 shipments valued at $26.9K USD.

India's gatifloxacin exports to Saudi Arabia are driven primarily by a handful of large-scale manufacturers. DOSHI MEDICARE PRIVATE LIMITED with 2 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 1 active exporters signals a competitive but concentrated market — buyers in Saudi Arabia benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — DOSHI MEDICARE PRIVATE LIMITED — together account for 100% of total trade value on this route. The average shipment value of $13.5K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

On the buying side, TO THE ORDER OF is the largest importer with 2 shipments worth $26.9K USD — representing 100% of all gatifloxacin imports from India on this route.